My guess is that folks are finally discovering
what a bargain it is--and they've put some of
their biotech gains here. I left a message with
the company this morning--they're probably getting
a busy signal if they're trying to return my call,
whoops. The gist of the message was that I'd like
to see them get this of the OTC.bb, at times the
MM's do not fill orders at all well, I've had
trouble with orders sitting all day long, with
only the first 500 shares filled--and yet tens
of thousands of shares fly across the level II
machine.
I regard CNSI as a terrific long term invesment,
as speculative as any biotech--but it rounds out
my portfolio nicely, I've got the gene therapy in
there, the genomics and pharmacogenomics, a few
cancer angles, the anti-angiogenesis for instance,
and I have this little fella--with their GGF2.
Imagine owning a biotech for a novel protein! Doesn't
sound as sexy as the genome stocks, but I think this is
one to hold for quite a few years--I've only had
it a year or two, and I add to my position when
I have free cash, or when the crummy MM's fill my
orders.
Expect volatility however, that is just part of the
game with these stocks below $5, don't let it shake
you up, that is always the trick isn't it--happy to
say I snagged quite a few shares when this was below
a buck.
Actually, if anybody from CNSI reads this thread,
you can answer my questions by responding to
Mike.McFarland@worldnet.att.net
I was also concerned that the recap database may be
loaded with a few too many applications for this GGF.
It wouldn't be fair if newbies stumbled onto this
and thought GGF2 was the cure to everything, I'm as
thrilled as anybody when a stock gets pumped up out
of the blue, but I'd rather be honest than rich.
We are sure to see this get into early clinic trials
for a few things, but I think somebody overshot at
recap. Any biologists lurking who want to sort out
what looks reasonable and what looks like extra stuff
from the query?
recap.com |
